Skip to main content
OpenTrials

Clinical trial condition

Emphysema

Explore clinical trials studying Emphysema. Study availability and eligibility vary by location and protocol.

80 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Emphysema trial results

Completed

GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study

NCT02525861

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Arizona Board of Regents, University of Arizona Tucson, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Cedars Sinai Medical Center, Division of Pulmonary and Critical Care Medicine Los Angeles, California, United States
  • University of California Davis Health System Sacramento, California, United States
View all 18 locations
View Trial Details
Completed

GLASSIA Infusion Rate Study

NCT01651351

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +11 more
Locations
  • Overland Park, Kansas, United States
View Trial Details
Completed

Pharmacokinetic Study of ARALAST (Human Alpha1- PI)

NCT00242385

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Adelaide, South Australia, Australia
  • Woodville, South Australia, Australia
  • Fitzroy, Victoria, Australia
  • Nedlands, Western Australia, Australia
View Trial Details
Completed

Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)

NCT00396006

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Adelaide, South Australia, Australia
  • Melbourne, Victoria, Australia
  • Nedlands, Western Australia, Australia
  • Otahuhu, Auckland, New Zealand
View Trial Details
Completed

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

NCT00161707

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Cleveland Clinic Foundation, Department of Pulmonary and Critical Care Medicine Cleveland, Ohio, United States
  • The University of Texas Health Science Center at Tyler Tyler, Texas, United States
View Trial Details
Completed

Alpha-1 Foundation Research Registry

NCT00499941

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Medical University of South Carolina. Division of Pulmonary and Critical Care Medicine Charleston, South Carolina, United States
View Trial Details
Completed

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"

NCT02001688

Conditions
Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida, Pulmonary, Critical Care & Sleep Medicine Gainesville, Florida, United States
  • The University of Texas Health Science Center at Tyler Center for Clinical Research Tyler, Texas, United States
View Trial Details

Related conditions